Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification

Robert Nelson, Lorinda J. Price, Alan B. Halsey, Stanley N. Graven, Lionel Resnick, Noorbibi K. Day, Richard F. Lockey, Robert A. Good

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To assess the sensitivity and specificity of polymerase chain reaction (PCR) in infants and children at risk for human immunodeficiency virus (HIV) infection. Design: A prospective, blinded study of 286 HIV- seropositive infants and children. Infection was diagnosed by antibody detection after 18 months of age, two positive direct tests (p24 aniigen and HIV culture), or the presence of an illness that defines the acquired immunodeficiency syndrome. Setting: University of South Florida and All Children's Hospital, St Petersburg, inpatient and outpatient centers. Participants: Two hundred eighty-six infants and children seropositive for HIV who were examined between July 1988 and September 1992. Main Outcome Measures: Sensitivity, specificity, and predictive values of a commercially available PCR test. Results: Five hundred sixty-seven PCR tests were performed on samples from 286 seropositive subjects followed up for a minimum of 16 months. Of the subjects, 105 were confirmed to be infected and 181 uninfected. Overall, 96 of 105 initial PCRs in infected subjects were positive (sensitivity, 91.4%; positive predictive value, 99%). If samples obtained during the first week of life are excluded, 95 of 100 samples were positive (sensitivity, 95%). Of 181 initial PCR tests from seropositive subjects who seroreverted, 180 were negative (specificity, 99.4%; negative predictive value, 95.2%). The predictive value of a positive test was 90.9% and that of a negative test was 93.1% in the first month of lite. All 145 initial samples obtained between 5 weeks and 12 months of age correctly predicted infection status (positive predictive value, 100%). Conclusions: Gene amplification by means of a commercially available PCR is useful in the diagnosis of HIV infection for infants born to seropositive mothers. Between day 7 through 1 year of age, HIV infection is accurately diagnosed by the PCR assay.

Original languageEnglish (US)
Pages (from-to)40-45
Number of pages6
JournalArchives of Pediatrics and Adolescent Medicine
Volume150
Issue number1
StatePublished - Jan 1996
Externally publishedYes

Fingerprint

Gene Amplification
Virus Diseases
HIV
Pediatrics
Polymerase Chain Reaction
Sensitivity and Specificity
Infection
Inpatients
Acquired Immunodeficiency Syndrome
Outpatients
Mothers
Outcome Assessment (Health Care)
Prospective Studies
Antibodies

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification. / Nelson, Robert; Price, Lorinda J.; Halsey, Alan B.; Graven, Stanley N.; Resnick, Lionel; Day, Noorbibi K.; Lockey, Richard F.; Good, Robert A.

In: Archives of Pediatrics and Adolescent Medicine, Vol. 150, No. 1, 01.1996, p. 40-45.

Research output: Contribution to journalArticle

Nelson, Robert ; Price, Lorinda J. ; Halsey, Alan B. ; Graven, Stanley N. ; Resnick, Lionel ; Day, Noorbibi K. ; Lockey, Richard F. ; Good, Robert A. / Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification. In: Archives of Pediatrics and Adolescent Medicine. 1996 ; Vol. 150, No. 1. pp. 40-45.
@article{915519b26f494bd0995ea756445efa71,
title = "Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification",
abstract = "Objective: To assess the sensitivity and specificity of polymerase chain reaction (PCR) in infants and children at risk for human immunodeficiency virus (HIV) infection. Design: A prospective, blinded study of 286 HIV- seropositive infants and children. Infection was diagnosed by antibody detection after 18 months of age, two positive direct tests (p24 aniigen and HIV culture), or the presence of an illness that defines the acquired immunodeficiency syndrome. Setting: University of South Florida and All Children's Hospital, St Petersburg, inpatient and outpatient centers. Participants: Two hundred eighty-six infants and children seropositive for HIV who were examined between July 1988 and September 1992. Main Outcome Measures: Sensitivity, specificity, and predictive values of a commercially available PCR test. Results: Five hundred sixty-seven PCR tests were performed on samples from 286 seropositive subjects followed up for a minimum of 16 months. Of the subjects, 105 were confirmed to be infected and 181 uninfected. Overall, 96 of 105 initial PCRs in infected subjects were positive (sensitivity, 91.4{\%}; positive predictive value, 99{\%}). If samples obtained during the first week of life are excluded, 95 of 100 samples were positive (sensitivity, 95{\%}). Of 181 initial PCR tests from seropositive subjects who seroreverted, 180 were negative (specificity, 99.4{\%}; negative predictive value, 95.2{\%}). The predictive value of a positive test was 90.9{\%} and that of a negative test was 93.1{\%} in the first month of lite. All 145 initial samples obtained between 5 weeks and 12 months of age correctly predicted infection status (positive predictive value, 100{\%}). Conclusions: Gene amplification by means of a commercially available PCR is useful in the diagnosis of HIV infection for infants born to seropositive mothers. Between day 7 through 1 year of age, HIV infection is accurately diagnosed by the PCR assay.",
author = "Robert Nelson and Price, {Lorinda J.} and Halsey, {Alan B.} and Graven, {Stanley N.} and Lionel Resnick and Day, {Noorbibi K.} and Lockey, {Richard F.} and Good, {Robert A.}",
year = "1996",
month = "1",
language = "English (US)",
volume = "150",
pages = "40--45",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification

AU - Nelson, Robert

AU - Price, Lorinda J.

AU - Halsey, Alan B.

AU - Graven, Stanley N.

AU - Resnick, Lionel

AU - Day, Noorbibi K.

AU - Lockey, Richard F.

AU - Good, Robert A.

PY - 1996/1

Y1 - 1996/1

N2 - Objective: To assess the sensitivity and specificity of polymerase chain reaction (PCR) in infants and children at risk for human immunodeficiency virus (HIV) infection. Design: A prospective, blinded study of 286 HIV- seropositive infants and children. Infection was diagnosed by antibody detection after 18 months of age, two positive direct tests (p24 aniigen and HIV culture), or the presence of an illness that defines the acquired immunodeficiency syndrome. Setting: University of South Florida and All Children's Hospital, St Petersburg, inpatient and outpatient centers. Participants: Two hundred eighty-six infants and children seropositive for HIV who were examined between July 1988 and September 1992. Main Outcome Measures: Sensitivity, specificity, and predictive values of a commercially available PCR test. Results: Five hundred sixty-seven PCR tests were performed on samples from 286 seropositive subjects followed up for a minimum of 16 months. Of the subjects, 105 were confirmed to be infected and 181 uninfected. Overall, 96 of 105 initial PCRs in infected subjects were positive (sensitivity, 91.4%; positive predictive value, 99%). If samples obtained during the first week of life are excluded, 95 of 100 samples were positive (sensitivity, 95%). Of 181 initial PCR tests from seropositive subjects who seroreverted, 180 were negative (specificity, 99.4%; negative predictive value, 95.2%). The predictive value of a positive test was 90.9% and that of a negative test was 93.1% in the first month of lite. All 145 initial samples obtained between 5 weeks and 12 months of age correctly predicted infection status (positive predictive value, 100%). Conclusions: Gene amplification by means of a commercially available PCR is useful in the diagnosis of HIV infection for infants born to seropositive mothers. Between day 7 through 1 year of age, HIV infection is accurately diagnosed by the PCR assay.

AB - Objective: To assess the sensitivity and specificity of polymerase chain reaction (PCR) in infants and children at risk for human immunodeficiency virus (HIV) infection. Design: A prospective, blinded study of 286 HIV- seropositive infants and children. Infection was diagnosed by antibody detection after 18 months of age, two positive direct tests (p24 aniigen and HIV culture), or the presence of an illness that defines the acquired immunodeficiency syndrome. Setting: University of South Florida and All Children's Hospital, St Petersburg, inpatient and outpatient centers. Participants: Two hundred eighty-six infants and children seropositive for HIV who were examined between July 1988 and September 1992. Main Outcome Measures: Sensitivity, specificity, and predictive values of a commercially available PCR test. Results: Five hundred sixty-seven PCR tests were performed on samples from 286 seropositive subjects followed up for a minimum of 16 months. Of the subjects, 105 were confirmed to be infected and 181 uninfected. Overall, 96 of 105 initial PCRs in infected subjects were positive (sensitivity, 91.4%; positive predictive value, 99%). If samples obtained during the first week of life are excluded, 95 of 100 samples were positive (sensitivity, 95%). Of 181 initial PCR tests from seropositive subjects who seroreverted, 180 were negative (specificity, 99.4%; negative predictive value, 95.2%). The predictive value of a positive test was 90.9% and that of a negative test was 93.1% in the first month of lite. All 145 initial samples obtained between 5 weeks and 12 months of age correctly predicted infection status (positive predictive value, 100%). Conclusions: Gene amplification by means of a commercially available PCR is useful in the diagnosis of HIV infection for infants born to seropositive mothers. Between day 7 through 1 year of age, HIV infection is accurately diagnosed by the PCR assay.

UR - http://www.scopus.com/inward/record.url?scp=0030061421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030061421&partnerID=8YFLogxK

M3 - Article

VL - 150

SP - 40

EP - 45

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 1

ER -